Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting.
Journal: Stem cell investigation
Published: January 25, 2021
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC.
Journal: medRxiv : the preprint server for health sciences
Published: December 10, 2020
Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population.
Journal: Bone marrow transplantation
Published: November 06, 2020
A Safe Anti-A2 Titer for a Successful A2 Incompatible Kidney Transplantation: A Single-center Experience and Review of the Literature.
Journal: Transplantation direct
Published: October 09, 2020
HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines.
Journal: Cells
Published: August 17, 2020
Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC.
Journal: JCI insight
Published: July 17, 2020
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis.
Journal: Journal of hematology & oncology
Published: October 26, 2019
A novel inflammatory role for platelets in sickle cell disease.
Journal: Platelets
Published: December 31, 2014
Last Updated: 09/26/2026